Clinical Trials Browser

Withdrawn × Thyroid Neoplasms × pembrolizumab × Clear all

NCT04731740 2024-03-25

Pembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid Cancer

Phase 2 Withdrawn

Thyroid Neoplasms